
















![]()
Q1: 2026-05-07 Earnings Summary
EPS of -$0.26 beats by $0.09
|
Revenue of
$7.28M
(99.78% Y/Y)
beats by $630.81K
Profound Medical Corp. (PRN:CA) Shareholder/Analyst Call May 13, 2026 10:00 AM EDT
Company Participants
Arun Menawat - Chairman of the Board & CEO
Levant Tinaz - Software Developer
Kelly Stratton
Thomas Tamberrino - Chief Commercial Officer
Presentation
Operator
Good morning, everyone, and thank you for standing by. My name is Gill, and I will be your operator for today. At this time, I would like to welcome each and every one of you to the Profound Medical 2026 Annual General Meeting Conference Call.
[Operator Instructions]. I will now turn the call over to Dr. Arun Menawat, Chairman and CEO of Profound Medical, Inc. Please go ahead.
Arun Menawat
Chairman of the Board & CEO
Thank you. Good morning, everyone. It's great to see everyone. I feel like I know everybody here. It is now 10:00 a.m., and I would like to ask that this meeting come to order. My name is Arun Menawat. I have the amazing honor of being the CEO of Profound Medical, and I will act as the Chair for today's meeting.
On behalf of Profound Medical, I'm pleased to welcome you to this meeting of shareholders. Before we proceed with the formal business of today's meeting, I would like to introduce the nominees of the Board of Directors of Profound Medical, who are present in person or via conference call today.
Brian Ellacott, Cynthia Lavoie, Murielle Lortie, Frank Baylis, Tom Wellner, Vafa Jamali and Arthur Rosenthal. Great to have most of you here. Some members of our management team are also present today, and I would like to introduce them as well.
Rashed Dewan, our CFO; Mathieu Burtnyk, our Company's President; and Tom Tamberrino, our Chief Commercial Officer. For those shareholders listening to this broadcast by way of webcast or conference call, you need not take any action during the formal part of today's meeting, and
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。